Browse Category

Lawsuits News 16 October 2025 - 7 December 2025

Dow Chemical Stock (DOW) in December 2025: Dividend Cut, Lawsuits and 2026 Recovery Hopes

Dow Chemical Stock (DOW) in December 2025: Dividend Cut, Lawsuits and 2026 Recovery Hopes

Dow Chemical stock – technically Dow Inc. (NYSE: DOW), the successor to The Dow Chemical Company – is limping into the end of 2025 after one of its roughest years since the pandemic. At Friday’s close on 5 December 2025, DOW was trading just under $23 per share, roughly 40–45% lower than a year ago and about 48% below its 52‑week high near $44. Simply Wall St+1 Smartkarma notes a year‑to‑date decline of about 43%, with the stock recently dipping to $22.87 in heavy volume. Smartkarma The damage hasn’t come from one single shock but from a cluster of negative
Coca-Cola (KO) Stock Outlook December 2025: Dividend King Faces Lawsuit Risk but Analysts Still See Upside

Coca-Cola (KO) Stock Outlook December 2025: Dividend King Faces Lawsuit Risk but Analysts Still See Upside

Data and news current through the close on December 4, 2025. This article is for informational purposes only and is not investment advice. Coca-Cola stock today: price, performance and valuation The Coca-Cola Company (NYSE: KO) closed at $70.54 on December 4, 2025, down about 0.37% for the day. Intraday, shares traded between $70.45 and $71.34 on volume of roughly 8.4 million shares. Investing.com Over the last 52 weeks, KO has traded between roughly $60.62 (low) and $74.38 (high), leaving the stock about 5% below its 52‑week peak and around 16–17% higher year-to-date in 2025. Macrotrends+1 On a fundamentals basis: Price
Synopsys (SNPS) Stock on December 3, 2025: Nvidia’s $2 Billion Bet, Class‑Action Lawsuits and New Analyst Forecasts

Synopsys (SNPS) Stock on December 3, 2025: Nvidia’s $2 Billion Bet, Class‑Action Lawsuits and New Analyst Forecasts

Synopsys, Inc. (NASDAQ: SNPS) is back in the market spotlight after a volatile few months. On Wednesday, December 3, 2025, the stock extended a sharp rebound driven by Nvidia’s $2 billion strategic investment, even as fresh class‑action lawsuits and mixed analyst messages kept risks firmly on the radar. As of the U.S. close on December 3, Synopsys shares were trading around the mid‑$460s, up roughly 4% on the day and about 20% above their early‑November lows, but still well below the 52‑week high near $652 reached before the September earnings shock.StockAnalysis+1 Below is a detailed look at what changed on
Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

On December 2, 2025, Bristol-Myers Squibb (NYSE: BMY) found itself at the center of two very different storylines: a revived $6.7 billion Celgene lawsuit and strong hematology data at ASH 2025. Together with a hefty dividend and low valuation multiples, these cross-currents are shaping how investors see BMY stock heading into 2026. BMY Stock Snapshot on 2 December 2025 On a day when the S&P 500 rose 0.25% and the Dow gained 0.39%, BMY underperformed peers: Johnson & Johnson ticked up slightly, while Pfizer and Abbott fell less than Bristol-Myers. MarketWatch For investors watching Google News and Discover, the headline
Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

Bristol-Myers Squibb (NYSE: BMY) has suddenly become one of the most eventful big pharma names to watch as of December 1, 2025. A major lawsuit has been allowed to proceed, new cell therapy approvals are landing, hematology data at ASH 2025 is impressive, and investors are reassessing the stock’s value, dividend and medium‑term growth story. Below is a deep dive into today’s key news, current price, latest forecasts and what it all might mean for BMY stock. This article is for information only and is not investment advice. BMY Stock Snapshot on 1 December 2025 In other words: BMY is
Standard Chartered PLC Hit by US$2.7bn 1MDB Lawsuit as It Accelerates Capital, Green Finance and Digital-Asset Push – 24 November 2025

Standard Chartered PLC Hit by US$2.7bn 1MDB Lawsuit as It Accelerates Capital, Green Finance and Digital-Asset Push – 24 November 2025

On 24 November 2025, Standard Chartered PLC finds itself in a paradoxical position: facing a major legal challenge in Singapore linked to the 1MDB scandal, while simultaneously showcasing strength in capital, sustainability, and digital innovation across its key markets. From a US$2.7 billion lawsuit being allowed to proceed, to early compliance with Nigeria’s new capital rules, a Green Halal pilot in Malaysia, fresh digital‑asset initiatives in Hong Kong, and a new private‑banking leadership appointment in North Asia, the London‑listed lender is at the centre of multiple storylines that matter to investors and regulators alike. theasianbanker.com+4Reuters+4TheCable+4 Singapore court clears US$2.7 billion
24 November 2025
Uber Stock Poised to Soar? Guggenheim’s $140 Price Target Explained

Uber Stock Today, November 20, 2025: AI Pay Lawsuit Triggers Sell‑Off Despite Robot Delivery Deal

Uber Technologies (NYSE: UBER) had a volatile session on Thursday, 20 November 2025, as investors weighed a fresh European legal challenge to the company’s AI‑driven pay systems against upbeat news on automation, travel partnerships and still‑bullish Wall Street views. By late trade, UBER had fallen sharply in the regular session to the mid‑$80s, down roughly 6–7% on the day, with intraday lows below $86 and lows near $83–84 on some feeds.Investing.com+1 Heavy trading pushed volume to about 34.5 million shares, one of the busiest days since Uber’s early‑November earnings report.Investing.com Yet in after‑hours trading, the stock bounced back toward $90, suggesting dip‑buyers
Broadcom’s $10B AI Chip Deal Ignites Stock Surge – What’s Powering This Tech Giant’s Boom

Broadcom Stock Today (Nov. 20, 2025): AVGO Rallies on AI Launch, Nvidia Results and Fidelity Lawsuit

Broadcom Inc. (NASDAQ: AVGO) is back in the spotlight on Thursday, November 20, 2025, as the stock extends a sharp rebound driven by powerful AI infrastructure news, Nvidia’s blockbuster earnings, and rising legal drama around VMware. On Wednesday, AVGO jumped about 4.1% to close near $354, with trading volume above 21 million shares.Investing.com+1 Pre‑market quotes early Thursday showed another ~3% gain, pushing the share price into the mid‑$360s and leaving the stock up roughly 45–50% year‑to‑date.Investing.com+1 Below is a breakdown of what’s moving Broadcom stock today, and what investors are watching next. Key takeaways for AVGO on November 20, 2025 Broadcom stock today: price
Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat Stock Crashes to $1 as Shareholders Face Massive Dilution and Lawsuit Risks – 19 November 2025

Published: 19 November 2025 Beyond Meat’s dramatic late‑October meme‑stock rally has given way to a brutal reality check. On 19 November 2025, the plant‑based meat pioneer is trading around $1 per share, down roughly 40% just this month and about 73% year‑to‑date, hovering near penny‑stock territory and flirting with Nasdaq’s minimum bid‑price rules. Stocktwits+1 At the same time, shareholders are being asked to approve a potentially highly dilutive financing package, while multiple securities‑fraud investigations gather steam. TradingView+2GlobeNewswire+2 Key takeaways today (19 November 2025) From meme darling back to distressed stock In late October, Beyond Meat briefly looked like the comeback story of the meme era. A combination of a
Genius Group (GNS) Soars on Market‑Manipulation Lawsuit: What Today’s 17 November 2025 Rally Really Means

Genius Group (GNS) Soars on Market‑Manipulation Lawsuit: What Today’s 17 November 2025 Rally Really Means

Genius Group Limited (NYSE American: GNS) is back in the spotlight today after its stock spiked more than 35–40% in U.S. pre‑market trading, driven by fresh attention on a newly filed $250 million federal securities class action lawsuit against Citadel Securities and Virtu Americas.Stocktwits+2Benzinga+2 By midday, the move has cooled but GNS is still trading around $0.86, up modestly on the session and with elevated volume, underscoring renewed retail interest in one of the market’s more controversial small‑cap education and Bitcoin plays. Stock Titan Below is everything investors and observers need to know about today’s move, the lawsuit, and how
Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Stock Hits a 52-Week Low on Legal Woes Kenvue’s shares collapsed to an all-time low since their mid-2023 IPO, closing around $14 after Thursday’s 13.2% plunge stocktwits.com. The one-day drop – Kenvue’s worst on record – was triggered by headline risks that blindsided investors. By early Friday, October 17, the stock stabilized slightly (up about 0.6% in pre-market trading) after the rout stocktwits.com. Still, at roughly 40% below its IPO price, the Johnson & Johnson spinoff has seen its market capitalization shrink to about $30–31 billion reuters.com. This dramatic sell-off came despite broader markets being relatively calm – the S&P
Virgin Galactic SPCE Stock Surges on Lawsuit Settlement and Purdue Mission News

Virgin Galactic SPCE Stock Surges on Lawsuit Settlement and Purdue Mission News

Stock Performance & Financials Virgin Galactic’s share price has been in a prolonged slump, though recent news has sparked a bounce. On Oct. 1, 2025 SPCE closed at $3.42 ts2.tech; by Oct. 16 it had rallied to about $4.89 Investing (and was up ~6.3% on the day). The stock traded in a rough range of $3.30–$3.70 through early Oct ts2.tech. Over 2025 the stock is still down roughly one-third (Benzinga reports –33% YTD Benzinga; TS2.Tech data shows ~–42% YTD through Sept ts2.tech), well underperforming the S&P500. SPCE remains extremely volatile (5‑year drawdown ~99% ts2.tech). Financially, Virgin Galactic remains pre‑revenue. Q2

Stock Market Today

Wilmar share price slips on Friday as palm oil traders brace for POC2026 and Feb 26 results

7 February 2026
Singapore, Feb 7, 2026, 15:31 SGT — Market closed. Wilmar International shares ended the week on a softer note, closing down 0.86% on Friday at S$3.44 in Singapore, with the market shut on Saturday. (Yahoo Finance) The pullback matters because Wilmar sits on the intersection of edible oils and global commodity flows. Traders are heading into a week that could reset expectations for crude palm oil prices, a key input across the sector. The stock’s next real test is not the weekend tape. It’s Monday’s reopen, and then a late-February earnings read that could force investors to pick a view
CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

7 February 2026
CapitaLand Investment shares rose 1.3% to S$3.12 on Friday, bucking a 0.8% drop in Singapore’s benchmark index. CapitaLand Integrated Commercial Trust reported a 16.4% jump in second-half distributable income, while CapitaLand Ascendas REIT posted a 1.4% full-year rise. CapitaLand China Trust saw full-year DPU fall to 4.82 cents amid weaker yuan and occupancy. CLI reports FY2025 results on Feb. 11.
Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

7 February 2026
Keppel shares closed at S$11.64 on Friday, up 0.17%, after surging 6.1% the previous day on stronger FY2025 profit and a larger dividend plan. The company bought back 151,400 shares for about S$1.74 million. Keppel reported a 29% rise in full-year profit to S$1.02 billion and proposed a total distribution of 47 cents per share, including a special dividend partly paid in Keppel REIT units.
Go toTop